Universal Biosensors Inc. (UBI) is a global leader in electrochemical biosensor technology, developing test strips for portable analyzers across various industries, including health, agriculture, and environment. UBI launched Sentia™ for wine analysis in 2021, Xprecia Prime™ for blood coagulation in 2022, and PETRACKR® in 2023 for veterinary blood glucose testing. Headquartered in Melbourne, Australia, UBI is listed on the Australian Securities Exchange (ASX:UBI).